1Langtry HD, Markham A, Fluvastatin: a revew of its use in lipid disorders[J]. Drugs,1999,57(4) :583-606.
2Yamamoto A, Hoshi K, Ichihara K. Fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl-CoA reductase, scavenges free radicals and inhibits lipid peroxidation in rat liver microsomes[J]. Eur J Pharmacol,1998,361(1):143-149.
3Bucher HC, Griffth LE, Guyatt GH. Systemic review on the rik and benefit of different cholesterol - lowering interventions[J]. Arterioscler Thromb Vase Biol,1999,19(2):187-195.
4Riegger G, Abletshauser C Ludwig M,et al. The effect of fluvastatin on cardiac events in patients with symptomatic coronary artery disease during one year of treatment [J].Atherosclerosis, 1999,144(1): 263-270.
5Ross R. Atheroselerosis- an inflammatory disease[J]. N Engl J Med,1999,340(2) :115-126.
6Aviram M, Hussein O, Rosenblat M,et al. Interactions of platelets, macrophages, and lipoproteins in hypereholessterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy[J]. J Cardiovase Pharmacol, 1998,31(7):39-45.
